Table 2:
PRES imaging patterns
| Imaging Pattern | Overall (No. pts) | Association Categories |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Allo-BMTCsA/FK (No. pts) | SOTCsA/FK (No. pts) | CsA (No. pts) | Inf/Sho (No. pts) | AutoImm (No. pts) | Chemo (No. pts) | Eclamp (No. pts) | Unknown (No. pts) | ||
| Holohemispheric watershed | 31 | 8 | 4 | – | 10 | 3 | 1 | 3 | 2 |
| Superior frontal sulcus | 37 | 12 | 6 | 1 | 6 | 3 | 2 | 4 | 3 |
| Dominant parietal/occipital | 30 | 7 | 5 | 1 | 13 | 1 | 1 | 1 | 1 |
| Partial and/or asymmetric PRES | 38 | 6 | 11 | 1 | 4 | 5 | 1 | 9 | 1 |
| Partial | 16 | 2 | 6 | 1 | 1 | 1 | – | 3 | 1 |
| Asymmetric | 16 | 2 | 4 | – | 1 | 4 | 1 | 5 | – |
| Partial and asymmetric | 5 | 2 | 1 | – | 1 | – | – | 1 | – |
| Total | 136 | 33 | 26 | 3 | 33 | 12 | 5 | 17 | 7 |
Note:—PRES indicates posterior reversible encephalopathy syndrome; No. pts, number of patients; Allo-BMT, allogeneic bone marrow transplant; SOT, solid organ transplant; CsA/FK, currently on cyclosporine or FK-506 (tacrolimus) immunosuppressive treatment (to control graft-versus-host disease or transplant rejection); CsA, cyclosporine treatment in marrow diseases; Inf/Sho, infection, bacteremia, sepsis, shock group; Chemo, postchemotherapy; Eclamp, eclampsia and delayed eclampsia; Unknown, no association or hypertension only.